Clinical trial
Meningococcal B Vaccination in University Students
NCT00443157 · Public Health England, Other · Completed
Key facts
| NCT number | NCT00443157 |
|---|---|
| Title | Meningococcal B Vaccination in University Students |
| Official title | A Phase II, Open Label, Randomised, Single Centre Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Three or Four Doses of Meningococcal Serogroup B Outer Membrane Vesicle (OMV) Vaccine MENZBTM When Administered to Healthy Adults (University Students) |
| Acronym | MNB3 |
| Lead sponsor | Public Health England, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neisseria Meningitidis Serogroup B |
| Intervention type | Biological |
| Interventions | Meningococcal B Vaccine NZ |
| Enrollment | 50 |
| Start date | Feb 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Mar 5, 2007 |
| Last update posted | Aug 29, 2018 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: